| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |